Immediate Impact
1 by Nobel laureates 58 standout
Citing Papers
Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies
2025 Standout
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
2025 Standout
Works of Ju‐Whei Lee being referenced
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2–negative breast cancer: A trajectory analysis of adverse events
2021
High Dose Daunorubicin Improves Survival in AML up to Age 60, Across All Cytogenetic Risk Groups Including Patients with Unfavorable Cytogenetic Risk, and FLT3-ITD Mutant AML: Updated Analyses from Eastern Cooperative Oncology Trial E1900
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ju‐Whei Lee | 53 | 32 | 46 | 26 | 153 | |
| Marie-Émilie Dourthe | 41 | 35 | 26 | 24 | 125 | |
| Morgani Rodrigues | 39 | 25 | 116 | 29 | 204 | |
| Daniela Piccioni | 61 | 91 | 72 | 21 | 212 | |
| Christina Große-Thie | 140 | 49 | 10 | 23 | 234 | |
| Lavinia Grapulin | 67 | 8 | 43 | 17 | 143 | |
| Ossama Maher | 35 | 66 | 52 | 29 | 151 | |
| Eleonora Biasin | 41 | 45 | 62 | 20 | 217 | |
| R. Mozzana | 54 | 22 | 68 | 24 | 194 | |
| Carlos R. Torres‐Cintrón | 60 | 12 | 24 | 23 | 136 | |
| Christiane Walter | 24 | 101 | 117 | 18 | 178 |
All Works
Login with ORCID to disown or claim papers
Loading papers...